Literature DB >> 6620024

Furosemide acutely decreases airways resistance in chronic bronchopulmonary dysplasia.

L C Kao, D Warburton, C W Sargent, A C Platzker, T G Keens.   

Abstract

We studied the effects of furosemide on pulmonary mechanics in 10 infants with bronchopulmonary dysplasia aged 41 +/- 1 (SE) weeks post-conception, gestational age at birth 30 +/- 1 wk, birth weight 1370 +/- 200 gm. Thoracic gas volume, airways resistance, and specific airway conductance were measured in an infant body pressure plethysmograph during quiet breathing. Dynamic pulmonary compliance was measured using an esophageal balloon. Infants with BPD had greater Raw, lower SGaw, and lower Cdyn than did 16 normal control infants. Within one hour after administration of furosemide 1 mg/kg IV to infants with BPD, Raw fell 36 +/- 13%, SGaw increased 84 +/- 22%, and Cdyn increased 54 +/- 13%; TGV did not change. Diuretic treatment of BPD in infants is associated with rapid, short-term improvement in Raw and Cdyn.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6620024     DOI: 10.1016/s0022-3476(83)80602-7

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  19 in total

Review 1.  A risk-benefit assessment of drugs used for neonatal chronic lung disease.

Authors:  D G Sweet; H L Halliday
Journal:  Drug Saf       Date:  2000-05       Impact factor: 5.606

Review 2.  Bronchopulmonary dysplasia: early diagnosis, prophylaxis, and treatment.

Authors:  A Greenough
Journal:  Arch Dis Child       Date:  1990-10       Impact factor: 3.791

Review 3.  Intravenous or enteral loop diuretics for preterm infants with (or developing) chronic lung disease.

Authors:  Audra Stewart; Luc P Brion
Journal:  Cochrane Database Syst Rev       Date:  2011-09-07

Review 4.  Diuretic therapy in children.

Authors:  C M Whight
Journal:  Indian J Pediatr       Date:  1988 Sep-Oct       Impact factor: 1.967

5.  Nebulized furosemide in the treatment of bronchopulmonary dysplasia in preterm infants.

Authors:  Jasmine Sahni; Stephanie J Phelps
Journal:  J Pediatr Pharmacol Ther       Date:  2011-01

Review 6.  ATS Core Curriculum 2017: Part II. Pediatric Pulmonary Medicine.

Authors:  Paul E Moore; Jason T Poston; Debra Boyer; Emily Barsky; Jonathan Gaffin; Kathleen B Boyne; Kristie R Ross; Laura Beth Mann Dosier; Timothy J Vece; Alicia M Casey; Sebastian K Welsh; J Wells Logan; Edward G Shepherd; Pelton A Phinzy; Howard B Panitch; Christina M Papantonakis; Eric D Austin; Amir B Orandi; Maleewan Kitcharoensakkul; Mark K Abe; Amjad Horani; Jordan S Rettig; Jessica Pittman
Journal:  Ann Am Thorac Soc       Date:  2017-08

7.  Acute Responses to Diuretic Therapy in Extremely Low Gestational Age Newborns: Results from the Prematurity and Respiratory Outcomes Program Cohort Study.

Authors:  Carol J Blaisdell; James Troendle; Anne Zajicek
Journal:  J Pediatr       Date:  2018-03-26       Impact factor: 4.406

8.  Bronchopulmonary dysplasia in preterm infants: pathophysiology and management strategies.

Authors:  Carl T D'Angio; William M Maniscalco
Journal:  Paediatr Drugs       Date:  2004       Impact factor: 3.022

9.  Variation in the use of diuretic therapy for infants with bronchopulmonary dysplasia.

Authors:  Jonathan L Slaughter; Michael R Stenger; Patricia B Reagan
Journal:  Pediatrics       Date:  2013-03-11       Impact factor: 7.124

10.  Effect of acetazolamide and amiloride against sodium metabisulphite-induced bronchoconstriction in mild asthma.

Authors:  B J O'Connor; C T Yeo; Y M Chen-Worsdell; P J Barnes; K F Chung
Journal:  Thorax       Date:  1994-11       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.